Cantor Raises Price Target On Trulieve's Stock Ahead Of Q1 Earnings Report – Benzinga

Cannabis company Trulieve Cannabis (OTC: TCNNF) is scheduled to release its first-quarter 2021 financial results on May 13, before the market opens, and will follow up with a conference call at 8.30 AM ET.

The Analyst

Ahead of the earnings report, Cantor Fitzgerald’s Pablo Zuanic raised the price target to $89 from $83 on Trulieve’s stock, while keeping an “Overweight“ rating.

Investment Thesis

Zuanic said Cantor Fitzgerald raised the price target based on increased long-term EBITDA projections.

“We believe near term sentiment will be dictated by management commentary during the 5/13 call regarding 1Q metrics, outlook and the contribution this year from new assets in Pennsylvania and Massachusetts,” Zuanic noted.

The company could report quarterly sales of $200 million, according to the analyst, which is somewhat higher than the FactSet consensus of $188 million. Furthermore, Zuanic pointed out that the company’s operations in Pennsylvania will be included in a report for the full first quarter of 2021, and should be “ a relevant contributor.”

This year, the cannabis company should also profit from starting sales in Massachusetts, finalizing the acquisition of Keystone Shops in Philadelphia in the second quarter and further growth of its current operations in Florida.

“Our valuation

Read More

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Scroll to Top